Literature DB >> 1653454

Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF.

G A Ferns1, E W Raines, K H Sprugel, A S Motani, M A Reidy, R Ross.   

Abstract

Approximately 30 to 40 percent of atherosclerotic coronary arteries treated by angioplasty or by bypass surgery occlude as a result of restenosis. This restenosis is due principally to the accumulation of neointimal smooth muscle cells, which is also a prominent feature of the advanced lesions of atherosclerosis. The factors responsible for the accumulation of intimal smooth muscle cells have not been identified. Platelet-derived growth factor (PDGF) is a potent smooth muscle chemoattractant and mitogen. It is present in platelets and can be formed by endothelium, smooth muscle, and monocyte-derived macrophages. The development of an intimal lesion in the carotid artery of athymic nude rats induced by intraarterial balloon catheter deendothelialization was inhibited by a polyclonal antibody to PDGF. These data demonstrate that endogenous PDGF is involved in the accumulation of neointimal smooth muscle cells associated with balloon injury and may be involved in restenosis after angioplasty, and perhaps in atherogenesis as well.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653454     DOI: 10.1126/science.1653454

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  195 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 3.  Molecular aspects of pathological processes in the artery wall.

Authors:  J W van Neck; H P Bloemers
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

4.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

5.  Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury.

Authors:  Bernard S Buetow; Kristen A Tappan; Jeffrey R Crosby; Ronald A Seifert; Daniel F Bowen-Pope
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 6.  Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes.

Authors:  Jane E B Reusch; Peter A Watson
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 7.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

8.  Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study.

Authors:  S Tanizawa; M Ueda; C M van der Loos; A C van der Wal; A E Becker
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

9.  TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.

Authors:  G A Stouffer; G K Owens
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Platelet-derived growth factor BB induces functional vascular anastomoses in vivo.

Authors:  D M Brown; S P Hong; C L Farrell; G F Pierce; R K Khouri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.